Alkermes to Host Conference Call to Discuss Fourth Quarter and Year-End 2016 Financial Results
February 08 2017 - 4:00PM
Business Wire
Alkermes plc (NASDAQ: ALKS) will host a conference call at 8:30
a.m. ET (1:30 p.m. GMT) on Wednesday, Feb. 15, 2017, to discuss the
company’s fourth quarter and year-end 2016 financial results.
Management will also discuss financial expectations for 2017 and
provide an update on the company.
The conference call will be webcast on the Investors section of
Alkermes’ website at www.alkermes.com or may be accessed by dialing
+1 888 424 8151 for U.S. callers and +1 847 585 4422 for
international callers. The conference call ID number is
6037988.
A replay of the conference call will be available from 11:00
a.m. ET (4:00 p.m. GMT) on Wednesday, Feb. 15, 2017, through 5:00
p.m. ET (10:00 p.m. GMT) on Wednesday, Feb. 22, 2017, and may be
accessed by visiting Alkermes’ website or by dialing +1 888 843
7419 for U.S. callers and +1 630 652 3042 for international
callers. The replay access code is 6037988.
About Alkermes plcAlkermes
plc is a fully integrated, global biopharmaceutical company
developing innovative medicines for the treatment of central
nervous system (CNS) diseases. The company has a diversified
commercial product portfolio and a substantial clinical pipeline of
product candidates for chronic diseases that include schizophrenia,
depression, addiction and multiple sclerosis. Headquartered in
Dublin, Ireland, Alkermes plc has an R&D center in Waltham,
Massachusetts; a research and manufacturing facility in Athlone,
Ireland; and a manufacturing facility in Wilmington, Ohio. For more
information, please visit Alkermes’ website
at www.alkermes.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170208006098/en/
Alkermes plcJennifer Zibuda, +1 781-609-6129Corporate
Communications
Alkermes (NASDAQ:ALKS)
Historical Stock Chart
From Mar 2024 to Apr 2024
Alkermes (NASDAQ:ALKS)
Historical Stock Chart
From Apr 2023 to Apr 2024